Table 2.
Group A (n = 24) | Group B (n = 27) | P | |
---|---|---|---|
Complete response | 6 (25.0) | 0 (0) | |
Partial response | 17 (70.8) | 13 (48.1) | |
Stable disease | 0 (0) | 9 (37.5) | |
Progressive disease | 1 (0.42) | 5 (18.5) | |
Response rate | 95.8% | 48.1% | < 0.001 |
Disease control rate | 95.8% | 81.5% | 0.053 |
Group A: hepatic arterial infusion of fluorouracil + capecitabine; Group B: capecitabine alone